Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASOS Regulatory News (ASC)

Share Price Information for ASOS (ASC)

Share Price is delayed by 15 minutes
Get Live Data
286.00    9.00 (3.25%)
Bid:
284.50
Ask:
286.50
Spread: 2.00 (0.703%)
Market Cap: £342.20m
ASC Live PriceLast checked at - London Stock Exchange

Intraday ASOS Share Chart

Holding(s) in Company

4 Dec 2020 09:27

RNS Number : 5940H
ASOS PLC
04 December 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ASOS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Details of person subject to the notification obligation

Name

The Capital Group Companies, Inc.

City and country of registered office (if applicable)

Los Angeles, USA

4. Full name of shareholder(s)  (if different from 3)

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached:

02/12/2020

6. Date on which issuer notified (DD/MM/YYYY):

04/12/2020

7. Total positions of person(s) subject to the notification obligation:

 

% of voting rights attached to shares

(total of 8.A)

% of voting rights through financial instruments

(total of 8.B.1 + 8.B.2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

9.95%

0.00%

9.95%

99,837,096

Position of previous notification (if applicable)

10.00%

0.00%

10.00%

 

       

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0030927254 Common Stock

 

9,932,226

 

9.95%

 

 

 

 

 

SUBTOTAL 8.A

9,932,226

9.95%

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

N/A

 

 

 

 

 

 

SUBTOTAL 8.B.1

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

N/A

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

       

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

 

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Capital Research and Management Company

9.95%

 

9.95%

EuroPacific Growth Fund (a mutual fund managed by Capital Research and Management Company)

5.98%

 

5.98%

Total

9.95%

 

9.95%

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional information:

 

The Capital Group Companies, Inc. ("CGC") is the parent company of Capital Research and Management Company ("CRMC") and Capital Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment management company that serves as investment manager to the American Funds family of mutual funds, other pooled investment vehicles, as well as individual and institutional clients. CRMC and its investment manager affiliates manage equity assets for various investment companies through three divisions, Capital Research Global Investors, Capital International Investors and Capital World Investors. CRMC is the parent company of Capital Group International, Inc. ("CGII"), which in turn is the parent company of four investment management companies ("CGII management companies"): Capital International, Inc., Capital International Limited, Capital International Sàrl and Capital International K.K. CGII management companies and CB&T primarily serve as investment managers to institutional and high net worth clients. CB&T is a U.S.-based investment management company that is a registered investment adviser and an affiliated federally chartered bank.

Neither CGC nor any of its affiliates own shares of the Issuer for its own account. Rather, the shares reported on this Notification are owned by accounts under the discretionary investment management of one or more of the investment management companies described above.

 

 

 

Place of completion

Los Angeles

Date of completion

04/12/2020

       

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEANALEAKEFEA
Date   Source Headline
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 20264:23 pmRNSLichfield Fulfilment Centre Disposal Completion
11th May 20267:00 amRNSDisposal of Lichfield fulfilment centre
1st May 202611:11 amRNSDirector/PDMR Shareholding
1st May 202611:07 amRNSAdmission of Shares and Total Voting Rights
28th Apr 202610:00 amRNSBlock Listing Application
24th Apr 202612:01 pmRNSDirector/PDMR Shareholding
24th Apr 202612:00 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSInterim results for the 26 weeks to 1 March 2026
15th Apr 202610:30 amRNSDirector Declaration
9th Apr 202612:44 pmRNSNotice of Results
25th Mar 20267:00 amRNSPre-close Trading Update
23rd Mar 202612:45 pmRNSHolding(s) in Company
13th Mar 202611:01 amRNSHolding(s) in Company
13th Mar 202611:00 amRNSHolding(s) in Company
13th Mar 202611:00 amRNSHolding(s) in Company
4th Mar 20265:00 pmRNSHolding(s) in Company
5th Feb 20265:00 pmRNSHolding(s) in Company
2nd Feb 20268:00 amRNSChange of Company Registrar
23rd Jan 20269:31 amRNSDirector/PDMR Shareholding
22nd Jan 20265:42 pmRNSResult of AGM
20th Jan 202611:07 amRNSDirector/PDMR Shareholding
14th Jan 202612:00 pmRNSDirector/PDMR Shareholding
5th Jan 202611:30 amRNSDirector/PDMR Shareholding
12th Dec 20255:00 pmRNSSAYE Scheme and Director/PDMR Dealing
8th Dec 20259:22 amRNSAnnual Financial Report
1st Dec 202511:00 amRNSTotal Voting Rights
25th Nov 20255:05 pmRNSDirector/PDMR Shareholding
24th Nov 20254:00 pmRNSHolding(s) in Company
21st Nov 20258:00 amRNSNon-Executive Director and Audit Chair Appointment
21st Nov 20257:00 amRNSFinal results for the 52 weeks to 31 August 2025
13th Nov 20257:00 amRNSNotice of Results & Confirmation of Board Changes
13th Nov 20257:00 amRNSASOS announces successful refinancing
10th Nov 20254:30 pmRNSBlock listing Interim Review
13th Oct 20253:00 pmRNSHolding(s) in Company
30th Sep 20257:00 amRNSFull Year Trading Update
31st Jul 20257:00 amRNSASOS announces Board changes
30th Jul 20255:30 pmRNSChange of Auditor
2nd Jul 20255:37 pmRNSDirector/PDMR Shareholding
17th Jun 20257:00 amRNSExecutive Director Change
12th May 20254:30 pmRNSBlock listing Interim Review
6th May 202512:05 pmRNSHolding(s) in Company
6th May 202512:00 pmRNSHolding(s) in Company
1st May 20259:30 amRNSTotal Voting Rights
24th Apr 20257:00 amRNSInterim results for the 26 weeks to 2 March 2025
21st Mar 20252:30 pmRNSHolding(s) in Company
21st Mar 20257:00 amRNSNotice of Results and Trading Update
19th Mar 20254:30 pmRNSHolding(s) in Company
13th Mar 20251:00 pmRNSHolding(s) in Company
6th Feb 202511:57 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.